Search Results
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
environment.12,13 About Wegovy® Injectable semaglutide 2.4 mg is marketed under the brand name Wegovy®. In the EU, Wegovy® is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults with a BMI of
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:15 ET Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
environment.12,13 About Wegovy® Injectable semaglutide 2.4 mg is marketed under the brand name Wegovy®. In the EU, Wegovy® is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adults with a BMI of
More news about: NOVO NORDISK INC.
Nov 05, 2025, 08:00 ET BioDlink Congratulates Lepu Biopharma on Securing Approval for the World's First Approved EGFR-Targeted ADC
production and subsequent PPQto meet aggressive regulatory submission goals and aligns with global GMP standards, including those of China, the U.S., and the EU. BioDlink's manufacturing facilities have obtained GMP certifications from several countries and Foreign Manufacturer Approval from Japan's PMDA. This
More news about: BioDlink Biopharm Co., Ltd.
Nov 05, 2025, 07:42 ET Jumptuit Awarded Trademarks in the European Union (EU)
"We are pleased to announce Trademark awards in the EU for Jumptuit's logo and brand as we launch the Company's strategic expansion into this major global market," said Jumptuit Group Founder and CEO, Donald Leka. "The EU is an exceptionally important global market and a global research
More news about: Jumptuit
Nov 05, 2025, 07:30 ET DeepL Unveils Next-Gen Language AI tools and Game-Changing Agentic Productivity Solution
in beta for enterprise customers, bringing nearly all the top twenty most spoken global languages to the platform. In the EMEA region, all 24 official EU languages will now be available, along with Croatian, Bosnian, Serbian, Swahili, Afrikaans, and Malagasy. In the Asia-Pacific region, new languages will
More news about: DeepL
Nov 05, 2025, 07:30 ET DeepL Unveils Next-Gen Language AI tools and Game-Changing Agentic Productivity Solution
in beta for enterprise customers, bringing nearly all the top twenty most spoken global languages to the platform. In the EMEA region, all 24 official EU languages will now be available, along with Croatian, Bosnian, Serbian, Swahili, Afrikaans, and Malagasy. In the Asia-Pacific region, new languages will
More news about: DeepL
Nov 05, 2025, 07:30 ET DeepL stellt KI-Sprachtools der nächsten Generation und agentische Produktivitätslösung vor
Sprachen ergänzt, sodass nahezu alle der 20 meistgesprochenen Sprachen weltweit abgedeckt sind. In der EMEA-Region werden künftig alle 24 offiziellen EU-Sprachen verfügbar sein, sowie Kroatisch, Bosnisch, Serbisch, Swahili, Afrikaans und Madagassisch. In der Region Asien-Pazifik kommen Hindi, Malaiisch,
More news about: DeepL
Nov 05, 2025, 07:30 ET DeepL presenterar nästa generations AI-verktyg för språk och en banbrytande produktivitetslösning
företagskunder, vilket innebär att nästan alla de tjugo mest talade språken i världen nu finns på plattformen. I EMEA-regionen kommer nu alla 24 officiella EU-språk att vara tillgängliga, tillsammans med kroatiska, bosniska, serbiska, swahili, afrikaans och malagassiska. I Asien-Stillahavsområdet kommer nya
More news about: DeepL
Nov 05, 2025, 07:30 ET DeepL introduceert next-gen Language AI-tools en een baanbrekende agentische productiviteitsoplossing
toegevoegd. Dit betekent dat bijna alle twintig wereldwijd meest gesproken talen op het platform beschikbaar zijn. In de EMEA-regio zijn nu alle 24 officiële EU-talen beschikbaar, waaronder Kroatisch, evenals talen als Bosnisch, Servisch, Swahili, Afrikaans en Malagassisch. In het Azië-Pacific-gebied zijn onder
More news about: DeepL
Nov 05, 2025, 07:00 ET Avanos Medical, Inc. Announces Third Quarter 2025 Results
divestiture of the Company's respiratory health business; Expenses associated with European Union Medical Device Regulation ("EU MDR") compliance; The amortization of intangible assets associated with business acquisitions; Impairments
More news about: Avanos Medical
Nov 05, 2025, 06:59 ET Drone (UAV) Payload Market worth $6.69 billion by 2030 - Exclusive Report by MarketsandMarkets™
warfare missions. Civil applications—such as infrastructure inspection, agriculture, and environmental monitoring—are rapidly expanding under harmonized EU drone regulations. Leading companies like Leonardo, Thales, Airbus, and Saab invest heavily in sensor miniaturization and multi-mission payload integration.
More news about: MarketsandMarkets
Nov 05, 2025, 06:27 ET Elanco Animal Health Reports Third Quarter 2025 Results
U.S. label updated to remove vaccine-induced disease language, and additional data submitted to FDA addressing vaccination response; launched in the EU, Great Britain, and Australia with a label consistent with other international markets where the product has already been approved
More news about: Elanco Animal Health
Nov 05, 2025, 04:11 ET Daqo to Showcase Integrated Electrical Solutions for a Smarter, Greener Grid at Enlit Europe 2025
face mounting pressure to integrate renewable energy, replace aging infrastructure, and comply with evolving regulations, including the upcoming 2026 EU phase-out of SF₆ in medium-voltage switchgear. At Bilbao Exhibition Centre, Daqo will showcase durable, sustainable, and regulation-ready alternatives
More news about: Daqo
Nov 05, 2025, 03:01 ET Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential
a coordinated launch across all key EU markets under the leading global antifungal brand Lamisil®. The agreement covers 19 European markets, representing a total population of approximately 500 million people including all major EU countries and the United Kingdom ("Big
More news about: Moberg Pharma
Nov 05, 2025, 02:58 ET Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential
a coordinated launch across all key EU markets under the leading global antifungal brand Lamisil®. The agreement covers 19 European markets, representing a total population of approximately 500 million people including all major EU countries and the United Kingdom ("Big
More news about: Moberg Pharma
Nov 05, 2025, 02:49 ET Karo Healthcare enters an exclusive license agreement with Moberg Pharma for MOB-015 in Europe
Lamisil®1. The agreement covers 19 markets, representing a total population of approximately 500 million people, including all major EU countries and the United Kingdom ("Big 5"). It also includes eleven countries where MOB-015 is already approved but not yet launched. In these markets,
More news about: Karo Healthcare
Nov 05, 2025, 01:55 ET Sinch reports third quarter 2025 results - Improved profitability and positioned for long-term growth
[email protected] Note: This information is such that Sinch AB (publ) is required to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on November 5 2025 through the agency of the contact person set out
More news about: Sinch AB
Nov 05, 2025, 01:50 ET Sinch reports third quarter 2025 results - Improved profitability and positioned for long-term growth
[email protected] Note: This information is such that Sinch AB (publ) is required to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on November 5 2025 through the agency of the contact person set out
More news about: Sinch AB
Nov 05, 2025, 00:49 ET Global Buyers Flock to Yiwu Global Digital Trade Center for Major Purchases
240,000 overseas buyers from 223 countries and regions — a 6.8% increase over the previous session — with particularly strong growth among buyers from the EU, Middle East, United States, and South America. Among these, 65% were visiting Yiwu for the first time, shifting from "sample viewing
More news about: Yiwu Global Digital Trade Center
Nov 05, 2025, 00:01 ET Radisson Hotel Group, Park Inn by Radisson Melbourne Carlton 개장으로 Park Inn by Radisson 첫선 보여
multimedia:https://www.prnewswire.com/kr/news-releases/u0072u0061u0064u0069u0073u0073u006Fu006Eu002Du0068u006Fu0074u0065u006Cu002Du0067u0072u006Fu0075u0070u002Cu002Du0070u0061u0072u006Bu002Du0069-302605065.html
More news about: Radisson Hotel Group
Nov 04, 2025, 20:56 ET 고션, 슬로바키아 최초의 배터리 공장을 정식 가동하면서 유럽 에너지 논리 재정립
발걸음이다. 95헥타르 면적의 기가팩토리는 초기 용량이 20GWh인 배터리를 생산하도록 설계되었으며, 2027년에 본격적인 생산을 시작할 예정이다. 모든 제품은 유럽연합(EU) 시장에 공급되는데, 이 계획이 순조롭게 진행된다면 고션이 EU 지역 내 공급 역량을 강화하고, 물류 효율성을 개선하며, 유럽의 친환경 산업 생태계에서 입지를 다질 수 있을 것으로 전망된다. 리젠(Li Zhen) 고션 회장은 "고션이 '슬로바키아에서 제조'된 배터리를 전 세계 친환경 에너지
More news about: Gotion
Nov 04, 2025, 16:01 ET PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
– Initiated US and EU launch of Sephience™ (sepiapterin) – – Strong initial Sephience uptake with global revenue of $19.6M and 521 start forms in the US
More news about: PTC Therapeutics, Inc.
Nov 04, 2025, 15:27 ET Huawei -- работая сообща ради более «зеленой» и полностью интеллектуальной Европы
https://www.huawei.com/eu/events/huaweiconnect-madrid Фото -
More news about: Huawei Technologies
Nov 04, 2025, 15:25 ET Huawei: Trabajando juntos por una Europa más verde e inteligente
https://www.huawei.com/eu/events/huaweiconnect-madrid Foto -
More news about: Huawei Technologies
Nov 04, 2025, 15:24 ET Huawei : travailler ensemble pour une Europe plus verte et plus intelligente
https://www.huawei.com/eu/events/huaweiconnect-madrid Photo -
More news about: Huawei Technologies